What is the 13F Pro Quality Score for EYPT?

13F Pro ranks EyePoint, Inc. (EYPT) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View EYPT's current score at https://13fpro.ai/company/EYPT (free sign-up required for the full ranking).

Where does 13F Pro source EYPT data?

All EyePoint, Inc. fundamentals and ownership data come directly from SEC EDGAR. EyePoint, Inc. files with the SEC under CIK 1314102. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is EYPT in?

EyePoint, Inc. (EYPT) is classified in the Technology sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/technology.

How often is EYPT research updated on 13F Pro?

EYPT's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

EyePoint, Inc.(EYPT)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Technology →Nasdaqsmall

Institutional-grade research for retail investors

SEC EDGAR: CIK 1314102 EYPT stock profile & AI dashboard →

13F Pro Quality Score

3.5/100

Rank #2,959 of 2,961 stocks

View Technology peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

0.7/100

Profitability

1.1/100

Balance Sheet

1.3/100

Earnings Quality

3.3/100

Free Cash Flow

0.6/100

Institutional Flow

40.6/100

Revenue Scale

1.9/100

Dilution Risk

3.4/100

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why EYPT Scores 4/100

exact factor attribution · 2026-09-11

EYPT's composite is held back by revenue growth and free cash flow. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Institutional flow

-0.5 pts

41th pct

Earnings growth

-2.3 pts

4th pct

Shareholder dilution

-2.3 pts

3th pct

Earnings quality

-4.7 pts

3th pct

Capital efficiency

-4.9 pts

1th pct

Scale

-7.2 pts

2th pct

Profitability

-7.3 pts

1th pct

Free cash flow

-7.4 pts

1th pct

Revenue growth

-9.9 pts

1th pct

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

EYPT Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for EyePoint, Inc. (EYPT), a Technology sector company. 13F Pro's AI-powered ranking engine scores EYPT at 3.5/100 on a 32-signal composite quality model, placing it at rank #2,959 of 2,961 stocks — the bottom half of the AI-ranked universe. Areas of concern include free cash flow (0.6) and revenue growth (0.7), which score below median versus the broader universe. Shareholder dilution risk is elevated at 3.4/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), EyePoint, Inc. reports quarterly revenue of $507.0K, net income of $-94.5M, free cash flow of $-63.5M. Top institutional holders of EYPT by reported 13-F value include SUVRETTA CAPITAL MANAGEMENT, BlackRock, Cormorant Asset Management, based on the most recent SEC filings. EYPT trades on the Nasdaq exchange and files with the SEC under CIK 1314102. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate EYPT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for EyePoint, Inc. directly from SEC EDGAR.

✦

Fun facts about EyePoint, Inc.

Quirks, history, and lore behind EYPT — the kind of stuff that makes a stock memorable.

1
The Basics
A small-cap biopharmaceutical company focused on specialty drug delivery · listed on Nasdaq · headquartered in Massachusetts.
2
The Numbers
Annual revenues in the low tens of millions of dollars — classic commercial-stage micro-cap territory, where every product approval is a make-or-break moment.
3
The History
The company traces its roots to work on sustained-release ocular implants — tiny devices that park a drug directly inside the eye for months at a time.
4
The Secret
Its proprietary Durasert platform is the secret sauce — a biodegradable or non-biodegradable implant technology licensed to bigger pharma partners as well as fielded in its own products.
5
The Lore
One of its flagship products targets chronic non-infectious uveitis affecting the posterior segment of the eye — a mouthful of a disease that affects a small but desperate patient population.
6
The Giveaway
The ticker practically spells out the mission: this eye-focused drug-delivery company, with EYPT on Nasdaq, wants to be the go-to name in long-lasting ocular therapeutics.

▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q2 2026

$507.0K

Net Income

Q2 2026

$-94.5M

Free Cash Flow

Q2 2026

$-63.5M

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Total Assets

-24.2% YoY

$228.2MFY 2026

FY23 $175.7MFY24 $324.2MFY25 $301.1MFY26 $228.2M

Total Debt

—FY 2026

FY23 $0.00FY24 —FY25 —FY26 —

Metric	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	$228.2M -24.2%	$301.1M -7.1%	$324.2M +84.6%	$175.7M -24.8%	$233.4M +30.5%	$178.8M
Total Debt	—	—	—	$0.00 -100.0%	$40.5M +11.7%	$36.2M

Get alerted when EYPT's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for EyePoint, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of EYPT

SUVRETTA CAPITAL MANAGEMENT, LLC
$118.6M8,296,375 sh
BlackRock, Inc.
$106.7M7,463,197 sh
Cormorant Asset Management, LP
$100.1M7,000,000 sh
FEDERATED HERMES, INC.
$81.2M5,681,052 sh
ADAGE CAPITAL PARTNERS GP, L.L.C.
$69.0M4,827,792 sh
FRANKLIN RESOURCES INC
$68.7M4,807,078 sh
Commodore Capital LP
$65.8M4,600,000 sh
Jupiter Topco LLC
$53.9M3,770,381 sh
VANGUARD CAPITAL MANAGEMENT LLC
$51.9M3,630,252 sh
Paradigm Biocapital Advisors LP
$41.3M2,890,397 sh

Fund	Value	Shares
SUVRETTA CAPITAL MANAGEMENT, LLC	$118.6M	8,296,375
BlackRock, Inc.	$106.7M	7,463,197
Cormorant Asset Management, LP	$100.1M	7,000,000
FEDERATED HERMES, INC.	$81.2M	5,681,052
ADAGE CAPITAL PARTNERS GP, L.L.C.	$69.0M	4,827,792
FRANKLIN RESOURCES INC	$68.7M	4,807,078
Commodore Capital LP	$65.8M	4,600,000
Jupiter Topco LLC	$53.9M	3,770,381
VANGUARD CAPITAL MANAGEMENT LLC	$51.9M	3,630,252
Paradigm Biocapital Advisors LP	$41.3M	2,890,397

More Technology Companies

View all Technology →

AGILENT TECHNOLOGIES, INC.

AAOI

APPLIED OPTOELECTRONICS, INC.

AAPL

Apple Inc.

ABNB

Airbnb, Inc.

ACCL

Acco Group Holdings Ltd

ACCS

ACCESS Newswire Inc.

ACFN

ACORN ENERGY, INC.

ACIW

ACI WORLDWIDE, INC.

Put EYPT on your watchlist

Track score changes the day EyePoint, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is EYPT a good stock to buy?

13F Pro's AI-powered analysis of EyePoint, Inc. (EYPT) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for EYPT are available on the EYPT stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. EYPT is classified as a small company.

Which hedge funds own EYPT?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling EYPT. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of EyePoint, Inc.'s investment landscape.